Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice
Copyright © 2021 Yamazaki, Kato, Tsuboi, Miyauchi, Suda, Sato, Nakajima, Yokoji-Takeuchi, Yamada-Hara, Tsuzuno, Matsugishi, Takahashi, Tabeta, Miura, Okuda, Kikuchi, Ohno and Yamazaki..
Background & Aims: Periodontitis increases the risk of nonalcoholic fatty liver disease (NAFLD); however, the underlying mechanisms are unclear. Here, we show that gut dysbiosis induced by oral administration of Porphyromonas gingivalis, a representative periodontopathic bacterium, is involved in the aggravation of NAFLD pathology.
Methods: C57BL/6N mice were administered either vehicle, P. gingivalis, or Prevotella intermedia, another periodontopathic bacterium with weaker periodontal pathogenicity, followed by feeding on a choline-deficient, l-amino acid-defined, high-fat diet with 60 kcal% fat and 0.1% methionine (CDAHFD60). The gut microbial communities were analyzed by pyrosequencing the 16S ribosomal RNA genes. Metagenomic analysis was used to determine the relative abundance of the Kyoto Encyclopedia of Genes and Genomes pathways encoded in the gut microbiota. Serum metabolites were analyzed using nuclear magnetic resonance-based metabolomics coupled with multivariate statistical analyses. Hepatic gene expression profiles were analyzed via DNA microarray and quantitative polymerase chain reaction.
Results: CDAHFD60 feeding induced hepatic steatosis, and in combination with bacterial administration, it further aggravated NAFLD pathology, thereby increasing fibrosis. Gene expression analysis of liver samples revealed that genes involved in NAFLD pathology were perturbed, and the two bacteria induced distinct expression profiles. This might be due to quantitative and qualitative differences in the influx of bacterial products in the gut because the serum endotoxin levels, compositions of the gut microbiota, and serum metabolite profiles induced by the ingested P. intermedia and P. gingivalis were different.
Conclusions: Swallowed periodontopathic bacteria aggravate NAFLD pathology, likely due to dysregulation of gene expression by inducing gut dysbiosis and subsequent influx of gut bacteria and/or bacterial products.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Frontiers in immunology - 12(2021) vom: 28., Seite 766170 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yamazaki, Kyoko [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Journal Article |
|---|
| Anmerkungen: |
Date Completed 18.02.2022 Date Revised 26.02.2024 published: Electronic-eCollection Citation Status MEDLINE |
|---|
| doi: |
10.3389/fimmu.2021.766170 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM332459659 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM332459659 | ||
| 003 | DE-627 | ||
| 005 | 20240229153930.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2021.766170 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1306.xml |
| 035 | |a (DE-627)NLM332459659 | ||
| 035 | |a (NLM)34707622 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yamazaki, Kyoko |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.02.2022 | ||
| 500 | |a Date Revised 26.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Yamazaki, Kato, Tsuboi, Miyauchi, Suda, Sato, Nakajima, Yokoji-Takeuchi, Yamada-Hara, Tsuzuno, Matsugishi, Takahashi, Tabeta, Miura, Okuda, Kikuchi, Ohno and Yamazaki. | ||
| 520 | |a Background & Aims: Periodontitis increases the risk of nonalcoholic fatty liver disease (NAFLD); however, the underlying mechanisms are unclear. Here, we show that gut dysbiosis induced by oral administration of Porphyromonas gingivalis, a representative periodontopathic bacterium, is involved in the aggravation of NAFLD pathology | ||
| 520 | |a Methods: C57BL/6N mice were administered either vehicle, P. gingivalis, or Prevotella intermedia, another periodontopathic bacterium with weaker periodontal pathogenicity, followed by feeding on a choline-deficient, l-amino acid-defined, high-fat diet with 60 kcal% fat and 0.1% methionine (CDAHFD60). The gut microbial communities were analyzed by pyrosequencing the 16S ribosomal RNA genes. Metagenomic analysis was used to determine the relative abundance of the Kyoto Encyclopedia of Genes and Genomes pathways encoded in the gut microbiota. Serum metabolites were analyzed using nuclear magnetic resonance-based metabolomics coupled with multivariate statistical analyses. Hepatic gene expression profiles were analyzed via DNA microarray and quantitative polymerase chain reaction | ||
| 520 | |a Results: CDAHFD60 feeding induced hepatic steatosis, and in combination with bacterial administration, it further aggravated NAFLD pathology, thereby increasing fibrosis. Gene expression analysis of liver samples revealed that genes involved in NAFLD pathology were perturbed, and the two bacteria induced distinct expression profiles. This might be due to quantitative and qualitative differences in the influx of bacterial products in the gut because the serum endotoxin levels, compositions of the gut microbiota, and serum metabolite profiles induced by the ingested P. intermedia and P. gingivalis were different | ||
| 520 | |a Conclusions: Swallowed periodontopathic bacteria aggravate NAFLD pathology, likely due to dysregulation of gene expression by inducing gut dysbiosis and subsequent influx of gut bacteria and/or bacterial products | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a NAFLD | |
| 650 | 4 | |a Porphyromonas gingivalis | |
| 650 | 4 | |a metabolome | |
| 650 | 4 | |a metagenomic analysis | |
| 650 | 4 | |a oral–gut connection | |
| 650 | 4 | |a periodontitis | |
| 650 | 4 | |a periodontopathic bacteria | |
| 650 | 7 | |a RNA, Ribosomal, 16S |2 NLM | |
| 700 | 1 | |a Kato, Tamotsu |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuboi, Yuuri |e verfasserin |4 aut | |
| 700 | 1 | |a Miyauchi, Eiji |e verfasserin |4 aut | |
| 700 | 1 | |a Suda, Wataru |e verfasserin |4 aut | |
| 700 | 1 | |a Sato, Keisuke |e verfasserin |4 aut | |
| 700 | 1 | |a Nakajima, Mayuka |e verfasserin |4 aut | |
| 700 | 1 | |a Yokoji-Takeuchi, Mai |e verfasserin |4 aut | |
| 700 | 1 | |a Yamada-Hara, Miki |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuzuno, Takahiro |e verfasserin |4 aut | |
| 700 | 1 | |a Matsugishi, Aoi |e verfasserin |4 aut | |
| 700 | 1 | |a Takahashi, Naoki |e verfasserin |4 aut | |
| 700 | 1 | |a Tabeta, Koichi |e verfasserin |4 aut | |
| 700 | 1 | |a Miura, Nobuaki |e verfasserin |4 aut | |
| 700 | 1 | |a Okuda, Shujiro |e verfasserin |4 aut | |
| 700 | 1 | |a Kikuchi, Jun |e verfasserin |4 aut | |
| 700 | 1 | |a Ohno, Hiroshi |e verfasserin |4 aut | |
| 700 | 1 | |a Yamazaki, Kazuhisa |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 12(2021) vom: 28., Seite 766170 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2021 |g day:28 |g pages:766170 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2021.766170 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2021 |b 28 |h 766170 | ||